Everolimus Shows Benefit Against SEGA Tumors While there is no “magic bullet” for tuberous sclerosis complex (TSC), researchers have demonstrated the power of everolimus to treat acute symptoms and, more significantly, reverse the effects of a genetic defect associated with the disease.
Read Featured ResearchResearch and Training Details | |
---|---|
Faculty | 42 |
Joint Appointment Faculty | 1 |
Research Fellows and Post Docs | 1 |
Research Graduate Students | 5 |
Total Annual Grant Award Dollars | $1,522,316 |
Total Annual Industry Award Dollars | $1,085,089 |
Clinical Activities and Training | |
---|---|
Staff Physicians | 1 |
Clinical Fellows | 5 |
Inpatient Encounters | 6,970 |
Outpatient Encounters | 33,193 |